Displaying 1 to 11 of 11 investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
23andMe Inc DNA testing and genome sequencing firm. |
United States | 22 May 2007 | Series A Initial investment. Round participant. Active |
|
|
Bayhill Therapeutics A biopharmaceutical company focused on the translation of research into therapeutics for the treatment of autoimmune diseases. |
United States | N/A |
||
|
|
Cellective Therapeutics Inc |
United States | N/A |
||
|
|
CGI Pharmaceuticals Inc A biopharmaceutical company developing small molecule therapeutics for multiple oncology and immunology-based indications. |
United States | N/A |
||
|
|
InterMune Inc Biotechnology company focused on the research, development and commercialization of innovative therapies in pulmonology and orphan fibrotic diseases. |
United States | N/A |
||
|
|
Intradigm Corp |
United States | N/A |
||
|
|
Kereos Inc Kereos, Inc. develops targeted molecular imaging agents and therapeutics designed to detect and treat cancer and cardiovascular disease. |
United States | N/A |
||
|
|
OncoMed Pharmaceuticals Inc Biotechnology company focused on scientific discoveries of cancer stem cells in solid tumors. |
N/A |
|||
|
|
OncoMed Pharmaceuticals Inc Biotechnology company focused on scientific discoveries of cancer stem cells in solid tumors. |
N/A |
|||
|
|
Proacta Inc |
United States | 1 Jun 2004 | Series A |
|
|
|
Tolerx Inc Developer of a novel therapies focusing on modulating T-cell activities for treating autoimmune diseases, diabetes, and cancer. |
United States | N/A |